The gut microbiome in human health and disease-Where are we and where are we going? A bibliometric analysis

被引:23
|
作者
Huang, Zhiqiang [1 ]
Liu, Kun [1 ]
Ma, Wenwen [1 ]
Li, Dezhi [1 ]
Mo, Tianlu [1 ]
Liu, Qing [1 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai, Peoples R China
基金
英国科研创新办公室;
关键词
gut microbiota; research trend; hot topics and frontiers; visualized analysis; human health and disease; LONGITUDINAL MULTI-OMICS; TRANSPLANTATION; WEB; ASSOCIATION; CAUSALITY; DYNAMICS; VIROME; CANCER;
D O I
10.3389/fmicb.2022.1018594
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundThere are trillions of microbiota in our intestinal tract, and they play a significant role in health and disease via interacting with the host in metabolic, immune, neural, and endocrine pathways. Over the past decades, numerous studies have been published in the field of gut microbiome and disease. Although there are narrative reviews of gut microbiome and certain diseases, the whole field is lack of systematic and quantitative analysis. Therefore, we outline research status of the gut microbiome and disease, and present insights into developments and characteristics of this field to provide a holistic grasp and future research directions. MethodsAn advanced search was carried out in the Web of Science Core Collection (WoSCC), basing on the term "gut microbiome" and its synonyms. The current status and developing trends of this scientific domain were evaluated by bibliometric methodology. CiteSpace was used to perform collaboration network analysis, co-citation analysis and citation burst detection. ResultsA total of 29,870 articles and 13,311 reviews were retrieved from the database, which involve 42,900 keywords, 176 countries/regions, 19,065 institutions, 147,225 authors and 4,251 journals. The gut microbiome and disease research is active and has received increasing attention. Co-cited reference analysis revealed the landmark articles in the field. The United States had the largest number of publications and close cooperation with other countries. The current research mainly focuses on gastrointestinal diseases, such as inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD), while extra-intestinal diseases are also rising, such as obesity, diabetes, cardiovascular disease, Alzheimer's disease, Parkinson's disease. Omics technologies, fecal microbiota transplantation (FMT) and metabolites linked to mechanism would be more concerned in the future. ConclusionThe gut microbiome and disease has been a booming field of research, and the trend is expected to continue. Overall, this research field shows a multitude of challenges and great opportunities.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going
    Dix, Caroline
    Lo, Tsun-Ho
    Clark, Georgina
    Abadir, Edward
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 14
  • [32] Lymph node metastasis in oral squamous cell carcinoma: Where we are and where we are going
    Cao, Lei-Ming
    Zhong, Nian-Nian
    Li, Zi-Zhan
    Huo, Fang-Yi
    Xiao, Yao
    Liu, Bing
    Bu, Lin-Lin
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (04):
  • [33] Laser-driven particle acceleration for radiobiology and radiotherapy: where we are and where we are going
    Giulietti, Antonio
    MEDICAL APPLICATIONS OF LASER-GENERATED BEAMS OF PARTICLES IV: REVIEW OF PROGRESS AND STRATEGIES FOR THE FUTURE, 2017, 10239
  • [34] Cannabinoids in the treatment of cancer anorexia and cachexia: Where have we been, where are we going?
    Seymour-Jackson, Emily
    Laird, Barry J. A.
    Sayers, Judith
    Fallon, Marie
    Solheim, Tora S.
    Skipworth, Richard
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2023, 10
  • [35] 2008 Whitmore Lecture: Radical prostatectomy-where we were and where we are going
    Walsh, Patrick C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (03) : 246 - 250
  • [36] Plant-based vaccines and cancer therapy: Where are we now and where are we going?
    Rahimian, Neda
    Miraei, Hamid Reza
    Amiri, Atefeh
    Ebrahimi, Mohammad Saeid
    Nahand, Javid Sadri
    Tarrahimofrad, Hossein
    Hamblin, Michael R.
    Khan, Haroon
    Mirzaei, Hamed
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [37] Controversial Link between Cannabis and Anticancer Treatments-Where Are We and Where Are We Going? A Systematic Review of the Literature
    Hanganu, Bianca
    Lazar, Diana Elena
    Manoilescu, Irina Smaranda
    Mocanu, Veronica
    Butcovan, Doina
    Buhas, Camelia Liana
    Szalontay, Andreea Silvana
    Ioan, Beatrice Gabriela
    CANCERS, 2022, 14 (16)
  • [39] Immune checkpoint inhibitors in the treatment of oesophageal squamous cell carcinoma: where are we and where are we going?
    Chen, Ning
    Xu, Xiaoling
    Fan, Yun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [40] Liver transplantation for non-resectable colorectal liver metastasis: where we are and where we are going
    Glinka, Juan
    Ardiles, Victoria
    Pekolj, Juan
    Mattera, Juan
    Sanchez Claria, Rodrigo
    de Santibanes, Eduardo
    de Santibanes, Martin
    LANGENBECKS ARCHIVES OF SURGERY, 2020, 405 (03) : 255 - 264